IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with a significant negative impact on the quality of life of patients. To date, the therapeutic landscape for the management of the disease has been extremely limited, resulting in a profound unmet need. Indeed, adalimumab, an anti...

Full description

Saved in:

Bibliographic Details
Published in:	Pharmaceutics Vol. 15; no. 10; p. 2450
Main Authors:	Malvaso, Dalma, Calabrese, Laura, Chiricozzi, Andrea, Antonelli, Flaminia, Coscarella, Giulia, Rubegni, Pietro, Peris, Ketty
Format:	Journal Article
Language:	English
Published:	Basel MDPI AG 01.10.2023 MDPI
Subjects:	bimekizumab biologics brodalumab Chemokines Cytokines Disease Health aspects hidradenitis suppurativa IL-17 inhibitors Inflammation Localization Metabolic syndrome Monoclonal antibodies Neutrophils Pathogenesis Pathophysiology Psoriasis Review secukinumab Skin Skin diseases Tumor necrosis factor Tumor necrosis factor-TNF
ISSN:	1999-4923, 1999-4923
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!